ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2011

Trabectedin in the treatment of metastatic soft-tissue sarcoma: cost-effectiveness and cost-utility are yet to be proved.

C Blomqvist et al.PubMed ↗Publisher ↗

No numbers read from the abstract.